Quantitative Reverse Transcription-PCR Assay for Detection of mRNA Encoding Full-Length Human Tissue Kallikrein 7: Prognostic Relevance of KLK7 mRNA Expression in Breast Cancer 3 (original) (raw)

Expression analysis of the human kallikrein 7 (KLK7) in breast tumors: a new potential biomarker for prognosis of breast carcinoma

Maroulio Talieri

Thrombosis and Haemostasis, 2003

View PDFchevron_right

Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: An independent indicator of favourable prognosis in breast cancer

R. Ponzone

British Journal of Cancer, 2002

View PDFchevron_right

Quantitative analysis of human kallikrein gene 14 expression in breast tumours indicates association with poor prognosis

R. Ponzone

British Journal of Cancer, 2002

View PDFchevron_right

Quantitative Reverse Transcription-PCR Assay for Detection of mRNA Encoding Full-Length Human Tissue Kallikrein 7: Prognostic Relevance of KLK7 mRNA Expression in Breast Cancer

Maroulio Talieri, Timo Lovgren

Clinical Chemistry, 2006

View PDFchevron_right

Human Kallikrein Gene 5 (KLK5) Expression by Quantitative PCR: An Independent Indicator of Poor Prognosis in Breast Cancer

Andrea Biglia

2002

View PDFchevron_right

Human tissue kallikrein 7, a novel biomarker for advanced ovarian carcinoma using a novel in situ quantitative method of protein expression

diane kowalski

Annals of Oncology, 2008

View PDFchevron_right

Kallikrein-related peptidase 6 (KLK6) expression differentiates tumor subtypes and predicts clinical outcome in breast cancer patients

Christoforos Haritos

Clinical and Experimental Medicine, 2018

View PDFchevron_right

Expression of human Kallikrein 14 (KLK14) in breast cancer

E. Mayordomo

2006

View PDFchevron_right

Integrated genomic characterization of the kallikrein gene locus in cancer.

H. H.

2012

View PDFchevron_right

Prognostic Implications of the Immunohistochemical Expression of Human Kallikreins 5, 6, 10 and 11 in Renal Cell Carcinoma

MICHAEL VASLAMATZIS

Tumor Biology, 2006

View PDFchevron_right

Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells

Manfred Schmitt

Biological Chemistry, 2000

View PDFchevron_right

Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types

nikhil patel

Oncotarget, 2018

View PDFchevron_right

Kallikrein 11 Down-regulation in Breast Carcinoma: Correlation With Prognostic Parameters

Hulya Yilmaz-aydogan

In Vivo, 2021

View PDFchevron_right

Unfavorable Prognostic Value of Human Kallikrein 7 Quantified by ELISA in Ovarian Cancer Cytosols

M. Massobrio

Clinical Chemistry, 2006

View PDFchevron_right

Characterisation of human kallikrein 6/protease M expression in ovarian cancer

W. Zhang

British journal of cancer, 2004

View PDFchevron_right

Higher human kallikrein gene 4 (KLK4) expression indicates poor prognosis of ovarian cancer patients

Riccardo Arisio

Clinical cancer research : an official journal of the American Association for Cancer Research, 2001

View PDFchevron_right

Expression analysis and study of KLK4 in benign and malignant breast tumours

Georgia Papachristopoulou

Thrombosis and Haemostasis, 2009

View PDFchevron_right

Human Kallikrein 13 Protein in Ovarian Cancer Cytosols: A New Favorable Prognostic Marker

Eleftherios Diam

Journal of Clinical Oncology, 2004

View PDFchevron_right

Identification of immunoreactive tissue kallikrein in human ductal breast carcinomas

carlos figueroa

Journal of Cancer Research and Clinical Oncology, 1995

View PDFchevron_right

Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer

Stefania Bellone

Clinical Cancer Research, 2005

View PDFchevron_right

Kallikreins 5, 6 and 10 differentially alter pathophysiology and overall survival in an ovarian cancer xenograft model

David Pépin, Zahra Sharif, Geneviève Huppé, Barbara Vanderhyden

PloS one, 2011

View PDFchevron_right

The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis

Ulf-Håkan Stenman

Cancer research, 2003

View PDFchevron_right

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: A new independent unfavourable prognostic biomarker

M. Massobrio

British Journal of Cancer, 2002

View PDFchevron_right

Down-regulation of kallikrein-related peptidase 5 (KLK5) expression in breast cancer patients: a biomarker for the differential diagnosis of breast lesions

Margaritis Avgeris

Clinical Proteomics, 2011

View PDFchevron_right

Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer

Nancy Ahmed

Biological chemistry, 2017

View PDFchevron_right

The androgen-regulated gene human kallikrein 15 (KLK15) is an independent and favourable prognostic marker for breast cancer

Yousef Abd

British Journal of Cancer, 2002

View PDFchevron_right

Distinctly Different Gene Structure of KLK4/KLK-L1 /Prostase/ARM1 Compared with Other Members of the Kallikrein Family: Intracellular Localization, Alternative cDNA Forms, and Regulation by Multiple Hormones

Ceren Korkmaz

DNA and Cell Biology, 2001

View PDFchevron_right

Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker

M. Massobrio

Cancer research, 2001

View PDFchevron_right